The cellular response to neuregulins is governed by complex interactions of the erbB receptor family.

AUTOR(ES)

Riese, D J

RESUMO

Deregulated signaling by the four members of the epidermal growth factor receptor tyrosine kinase family (erbB family) is implicated in the genesis or progression of human cancers. However, efforts to analyze signaling by these receptors have been hampered by the diversity of ligands and extensive interreceptor cross talk. We have expressed the four human erbB family receptors, singly and in pairwise combinations, in a pro-B-lymphocyte cell line (Ba/F3) and investigated the range of interactions activated by the epidermal growth factor homology domain of the agonist neuregulin beta. The results provide the first comprehensive analysis of the response of this receptor family to a single peptide agonist. This peptide induced complex patterns of receptor tyrosine phosphorylation and regulation of Ba/F3 cell survival and proliferation. These data demonstrate the existence of several previously undocumented receptor interactions driven by neuregulin.

Documentos Relacionados

• Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains
• Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
• Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.
• The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
• Transmembrane Peptides as Inhibitors of ErbB Receptor Signaling